J Matern Fetal Neonatal Med. 2019 Apr 09;1-8. doi: 10.1080/14767058.2019.1588876. Epub 2019 Apr 09.
Prenatal opioid exposure heightens sympathetic arousal and facial expressions of pain/distress in term neonates at 24-48 hours post birth.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Christiana N Oji-Mmuo, Rebecca R Speer, Fumiyuki C Gardner, Megan M Marvin, Alexia C Hozella, Kim K Doheny
Affiliations
Affiliations
- a Department of Pediatrics, Division of Neonatal-Perinatal Medicine , Penn State Health Children's Hospital , Hershey , PA , USA.
- b Department of Pediatrics , Penn State College of Medicine , Hershey , PA , USA.
- c Department of Neural and Behavioral Sciences , Penn State College of Medicine , Hershey , PA , USA.
PMID: 30821185
PMCID: PMC7197408 DOI: 10.1080/14767058.2019.1588876
Abstract
PURPOSE: The rising issue of opioid use during pregnancy poses an increased risk of fetal exposure to opioids in-utero and the development of neonatal abstinence syndrome (NAS). The cessation of exposure to opioids upon birth causes elevated levels of norepinephrine in the circulation enhancing sympathetic arousal. Skin conductance (SC) detects sympathetic-mediated sweating while the Neonatal Facial Coding System (NFCS) depicts facial expressions of stress and pain. We hypothesize that there will be a direct correlation between SC and NFCS scores, such that neonates with prenatal opioid exposure will have higher SC and facial responses to pain/stress as compared with healthy neonates without prenatal opioid exposure.
OBJECTIVE: This study evaluates the utility of SC and the NFCS in the objective assessment of early postnatal pain response in opioid-exposed and non-opioid exposed neonates.
METHODS: This prospective, single-center, pilot study enrolled opioid-exposed term neonates (>37 weeks) and healthy controls. Subjects were observed within 24-48 hours post-birth (and prior to opioid withdrawal) for pain at baseline, during, and post-heel lance/squeeze (HLS) with simultaneously measured SC and videotaped facial expressions. SC data included electro-dermal responses over time (EDR/second) and the average amplitude of responses (mean of peaks [MP]). Video data were scored using the NFCS by two trained coders with inter-rater agreement >85%.
RESULTS: SC and NFCS scores were significantly associated with both groups. The opioid-exposed neonates had significantly higher skin conductance indices, EDR/sec for the HLS phase, and MP for HLS and post phases as compared with controls (p < .05). Opioid-exposed neonates demonstrated higher NFCS at baseline (p = .003).
CONCLUSIONS: Prenatal opioid exposure was associated with heightened sympathetic arousal during both pain and recovery phases and higher facial expressions of pain/distress at baseline only. A multimodal system of assessment may be useful in understanding the complexity and severity of opioid withdrawal associated with NAS.
Keywords: Neonatal Facial Coding System; Neonatal abstinence syndrome; neonatal opioid withdrawal; neonatal pain; skin conductance
References
- Curr Opin Pediatr. 2012 Apr;24(2):252-8 - PubMed
- Addict Dis. 1975;2(1-2):141-58 - PubMed
- Pain. 1987 Mar;28(3):395-410 - PubMed
- Acta Paediatr. 2016 Mar;105(3):e99-e106 - PubMed
- Pediatrics. 2004 Jul;114(1):65-72 - PubMed
- Pediatrics. 2000 Feb;105(2):454-61 - PubMed
- Arch Dis Child Fetal Neonatal Ed. 2000 Sep;83(2):F143-7 - PubMed
- J Matern Fetal Neonatal Med. 2018 Dec;31(23):3209-3213 - PubMed
- J Pediatr. 1977 Oct;91(4):638-41 - PubMed
- Acta Paediatr. 2008 Jan;97(1):27-30 - PubMed
- Clin Pediatr (Phila). 1975 Jun;14(6):592-4 - PubMed
- Pain. 1998 Jun;76(3):277-86 - PubMed
- J Pain. 2009 Feb;10(2):214-20 - PubMed
- Brain Res Brain Res Rev. 2001 Dec;38(1-2):1-19 - PubMed
- Res Nurs Health. 2009 Aug;32(4):465-74 - PubMed
- Psychophysiology. 2013 Jan;50(1):15-22 - PubMed
- Brain Res Bull. 2018 Apr;138:106-111 - PubMed
- Front Pediatr. 2017 Sep 20;5:204 - PubMed
- Eur J Pediatr. 2016 Jun;175(6):859-68 - PubMed
- Clin J Pain. 2008 Jul-Aug;24(6):479-96 - PubMed
- J Matern Fetal Neonatal Med. 2013 Sep;26(14):1399-403 - PubMed
- Arch Dis Child Fetal Neonatal Ed. 2016 Jan;101(1):F26-30 - PubMed
- J Dev Behav Pediatr. 1998 Apr;19(2):89-93 - PubMed
- Early Hum Dev. 2011 Jan;87(1):37-42 - PubMed
- Early Hum Dev. 2006 Sep;82(9):603-8 - PubMed
- Pain. 2008 Aug 31;138(2):460-71 - PubMed
- Clin J Pain. 2007 Jun;23(5):417-24 - PubMed
- J Perinatol. 2015 Aug;35(8):650-5 - PubMed
- Pediatrics. 2012 Feb;129(2):e540-60 - PubMed
- Arch Dis Child Fetal Neonatal Ed. 2016 Jan;101(1):F2-3 - PubMed
- J Matern Fetal Neonatal Med. 2012 Jun;25(6):796-801 - PubMed
- Pediatrics. 2014 Aug;134(2):e547-61 - PubMed
- Early Hum Dev. 2013 Mar;89(3):153-8 - PubMed
- J Matern Fetal Neonatal Med. 2016;29(15):2531-6 - PubMed
- Res Nurs Health. 1990 Oct;13(5):311-8 - PubMed
- N Engl J Med. 2016 Dec 22;375(25):2468-2479 - PubMed
- Paediatr Anaesth. 2013 Aug;23(8):761-3 - PubMed
- Arch Pediatr Adolesc Med. 2001 Feb;155(2):173-80 - PubMed
Publication Types
Grant support